Orchestra BioMed Holdings, Inc.·4

May 10, 5:18 PM ET

Taylor Andrew Lawrence 4

4 · Orchestra BioMed Holdings, Inc. · Filed May 10, 2024

Insider Transaction Report

Form 4
Period: 2024-05-08
Taylor Andrew Lawrence
Chief Financial Officer
Transactions
  • Award

    Common Stock, par value $0.0001 per share ("Common Stock")

    2024-05-08+100,000378,363 total
Footnotes (1)
  • [F1]Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest as follows: (i) 15,000 RSUs will vest on May 20, 2025, and (ii) the remaining 85,000 RSUs will vest in equal installments on August 20, 2025, November 20, 2025, December 20, 2025, May 20, 2026, August 20, 2026, November 20, 2026, March 25, 2027, May 20, 2027, August 20, 2027, November 20, 2027, March 25, 2028 and May 20, 2028, subject to the Reporting Person's continuous service through such dates.

Documents

1 file
  • 4
    tm2414108-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT